The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Alpha-1-antitrypsin deficiency

Faculty of Medicine / Department of Clinical Sciences, Lund / Section II / Respiratory Medicine, Allergology, and Palliative Medicine
Alpha-1-antitrypsin deficiency's profile in Lund University Research portal

Description

The research group conducts research on the clinical course and risk of developing lung disease, liver disease and other diseases in alpha-1-antitrypsin deficiency (AAT deficiency). Some of the research is based on the Swedish National Register of individuals with severe alpha-1 antitrypsin deficiency (AAT). The research group also follows a unique cohort of individuals with severe and moderate AAT deficiency identified through neonatal screening between 1972-194. The cohort is the only group of deficient individuals in the world, identified at birth and followed up regularly throughout life.

Staff

P